Tend was founded by Thomas Lendvay, Kathleen Lendvay.

Who are Tend's investors?

Tend's investors include SeaChange, Addition, GV (Google Ventures), Redpoint Ventures, Zigg Capital.

How much funding has Tend raised?

Tend has disclosed $125M raised across 1 round.

Where is Tend headquartered?

Tend is headquartered in Seattle, US.

Tend

Seattle, US · 6 known investors

Find your way into Tend

42 people in our graph share verified history with the Tend team — schools, employers, funds. One of them is your warm intro.

Sharon Kedarunlockedknows Thomas Lendvay · together at Rice University (overlapped)

×6knows the team · via Rice University

knows the team · via University of Washington - School of Medicine

knows the team · via C-SATS, Inc.

knows the team · via Temple University - Lewis Katz School of Medicine

knows the team · via CVS Pharmacy

Tend develops therapeutic solutions and diagnostic tools focused on the gut microbiome to treat chronic intestinal and digestive health conditions. The company serves researchers, clinicians, and patients seeking evidence-based alternatives to traditional disease management approaches.

Biotech Healthtech Medical Devices

Founders & leadership

Thomas Lendvay inCo-founder & CEOThomas Lendvay is a pediatric urologist and professor at the University of Washington and Seattle Children's Hospital with expertise in surgical technology and medical device design. He co-founded Tend to develop microbiome diagnostics and restoration tools for treating chronic digestive conditions, and also co-founded Singletto, which applies light-activated dye technology to pathogen inactivation.

Kathleen LendvayinCo-founder & COO

Investors · 6

SeaChange$250K – $1M

Additionreported · 2 sourcesNew York · $1M – $500M

GV (Google Ventures)reported · 2 sourcesMountain View · $250K – $50M

Redpoint VenturesreportedWoodside · $100K – $10M

Zigg CapitalreportedNew York · $4M

Also in the syndicate · 1

Juxtapose

Funding

SEC filings, press & company announcements

$125M disclosed across 1 round · 2021

$125MSeries CApr 2021 · 2 sources
Addition (lead), GV, Juxtapose, Redpoint, Zigg Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Dental tech startup Tend raises $125M in Series C funding to make going to the dentist feel like a modern experience - Tech Startupstechstartups.com · Apr 2021

Tend Raises $125M in Series C Funding Led by Additionprnewswire.com · Apr 2021

Tend Raises $37M in Series B Funding - FinSMEsfinsmes.com · Oct 2020

Tend Raises $37M Series B Led By GVprnewswire.com · Oct 2020

Tend Raises $36 Million To Make Going To The Dentist More Funpulse2.com · Oct 2019

Frequently asked questions

What does Tend do?: Tend develops therapeutic solutions and diagnostic tools focused on the gut microbiome to treat chronic intestinal and digestive health conditions. The company serves researchers, clinicians, and patients seeking evidence-based alternatives to traditional disease management approaches.
Who founded Tend?: Tend was founded by Thomas Lendvay, Kathleen Lendvay.
Who are Tend's investors?: Tend's investors include SeaChange, Addition, GV (Google Ventures), Redpoint Ventures, Zigg Capital.
How much funding has Tend raised?: Tend has disclosed $125M raised across 1 round.
Where is Tend headquartered?: Tend is headquartered in Seattle, US.